Dispatch Tribunal |
La Jolla Pharmaceutical Company Announces Financial Results for the Three and Twelve Months Ended December ...
GuruFocus.com Secondary efficacy endpoints include: (i) the change in serum ferritin, the other key measurement used to detect iron overload, from baseline to end of treatment; and (ii) the requirement for and frequency of phlebotomy procedures used during the study ... Financial Newsletter - Zacks La Jolla Pharmaceutical Company - LJPC - Stock Price Today - Zacks |
from phlebotomy - Google News http://bit.ly/2CFcvZ0
No comments:
Post a Comment